KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Payables (2016 - 2025)

Cme (CME) has disclosed Payables for 17 consecutive years, with $71.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Payables fell 91.35% to $71.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $71.8 million, a 91.35% decrease, with the full-year FY2025 number at $71.8 million, down 91.35% from a year prior.
  • Payables was $71.8 million for Q4 2025 at Cme, down from $74.9 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $879.6 million in Q3 2024 to a low of $47.2 million in Q2 2021.
  • A 5-year average of $347.1 million and a median of $100.9 million in 2022 define the central range for Payables.
  • Peak YoY movement for Payables: soared 1568.76% in 2024, then crashed 91.48% in 2025.
  • Cme's Payables stood at $798.2 million in 2021, then tumbled by 82.79% to $137.4 million in 2022, then tumbled by 34.06% to $90.6 million in 2023, then surged by 815.78% to $829.7 million in 2024, then tumbled by 91.35% to $71.8 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Payables are $71.8 million (Q4 2025), $74.9 million (Q3 2025), and $92.3 million (Q2 2025).